首页|宣肺降浊清肠汤治疗稳定期支气管扩张症疗效及对肠道微生态的影响

宣肺降浊清肠汤治疗稳定期支气管扩张症疗效及对肠道微生态的影响

扫码查看
目的 观察宣肺降浊清肠汤治疗稳定期支气管扩张患者的效果及对肠道微生态的影响.方法 选取2022 年1 月—2023 年1 月广州医科大学附属第一医院收治的稳定期支气管扩张症痰湿蕴肺型患者90 例为观察对象,随机分为西药组、中药组、中西医结合组,每组各30 例;同时于广州医科大学附属第一医院体检中心随机选取30 例健康者作为空白组,用于肠道菌群检测的对照.西药组给予氨溴索口服,中药组给予宣肺降浊清肠汤颗粒剂口服,中西医结合组给予宣肺降浊清肠汤联合氨溴索口服.连续治疗6 个月后评估3 组临床疗效,比较3 组治疗前后肺功能指标[第一秒用力呼气容积(FEV1)、用力肺活量(FVC)、呼气峰值流速(PEF)]、支气管扩张严重程度指数(BSI)评分、24 h痰量、急性加重次数、咳嗽-咳痰评估问卷(CASA-Q)评分、圣乔治呼吸问卷(SGRQ)评分及粪便标本中直肠真杆菌、多形拟杆菌表达量(采用PCR扩增法测定).结果 治疗结束后,中西医结合组临床总有效率明显高于中药组、西药组[93.3%(28/30)比63.3%(18/30)、76.7%(23/30),P均<0.05].与治疗前比较,治疗后3 组FEV1、FVC、PEF均明显提高,BSI评分、SGRQ评分均明显降低,24 h痰量、急性加重次数均明显减少,CASA-Q评分均明显升高,且中西医结合组各指标改善情况均明显优于中药组及西药组,西药组各指标改善情况均明显优于中药组,差异均有统计学意义(P均<0.05).治疗后中西医结合组和中药组粪便中直肠真杆菌、多形拟杆菌表达量均较治疗前明显改善(P均<0.05),西药组粪便直肠真杆菌、多形拟杆菌表达量均无明显变化(P均>0.05);治疗后中药组和中西医结合组直肠真杆菌表达量均明显低于西药组(P均<0.05),多形拟杆菌表达量均明显高于西药组(P均<0.05),中药组和中西医结合组直肠真杆菌、多形拟杆菌表达量比较差异均无统计学意义(P均>0.05).结论 宣肺降浊清肠汤联合氨溴索治疗稳定期支气管扩张症痰湿蕴肺型患者效果优于二者单独应用,可有效缓解患者病情,改善肺功能和生活质量,机制可能与宣肺降浊清肠汤可调节肠道菌群微生态相关.
Efficacy of decoction for diffusing lung,discharging turbid and calming panting on stable bronchiectasis and its effect on intestinal microecology
Objective It is to observe the effect of decoction for diffusing lung,discharging turbid and calming panting on stable bronchiectasis and its effect on intestinal microecology.Methods Ninety patients with stable bronchiectasis of syn-drome of phlegm-dampness accumulating lung treated in the First Affiliated Hospital of Guangzhou Medical University from January 2022 to January 2023 were selected as the observed subjects,and were randomly divided into western medicine group,Chinese medicine group,and combined traditional Chinese and western medicine group(combined group),with 30 cases in each group;meanwhile,30 healthy persons were randomly selected from the Physical Examination Center of the First Affiliated Hospital of Guangzhou Medical University as the blank group for the control of intestinal flora detection.The western medicine group was given ambroxol orally,the Chinese medicine group was given granules of decoction for diffusing lung,discharging turbid and calming panting orally,and the combined group was given decoction for diffusing lung,dis-charging turbid and calming panting combined with ambroxol orally.The clinical efficacy of the three groups was evaluated after 6 months of treatment,and the pulmonary function indexes[forced expiratory volume in one second(FEV1),forced volume capacity(FVC),peak expiratory flow(PEF)],bronchodilatation severity index(BSI),24-h sputum volume,a-cute exacerbation frequency,cough and sputum assessment questionnaire(CASA-Q)scores,and St.George's Respiratory Questionnaire(SGRQ)scores,and the expressions of Eubacterium rectale and Bacteroides thetaiotaomicron in fecal speci-mens(determined by PCR amplification)before and after treatment were compared among the three groups.Results At the end of treatment,the total clinical effective rate of the combined group was significantly higher than that of the traditional Chinese medicine group and western medicine group[93.3%(28/30)VS.63.3%(18/30),76.7%(23/30),all P<0.05].Compared with before treatment,FEV1,FVC and PEF were significantly increased,BSI scores and SGRQ scores,24-h sputum volume and acute exacerbation frequency were significantly reduced,the CASA-Q scores were significantly in-creased after treatment in the three groups,and the improvements of these indexes of the combined group were significantly better than those of the Chinese medicine group and western medicine group,the western medicine group was significantly better than the Chinese medicine group,the differences were all statistically significant(all P<0.05).The expressions of Eubacterium rectale and Bacteroides thetaiotaomicron in fecal specimens of the combined group and Chinese medicine group were improved significantly after treatment compared with before treatment(all P<0.05),the changes in the expressions of Eubacterium rectale and Bacteroides thetaiotaomicron were not significant in the western medicine group after treatment(all P>0.05);after treatment,the expressions of Eubacterium rectale of the combined group and traditional Chinese med-icine group were significantly lower than that of the western medicine group(both P<0.05),and the expression of Bacte-roides thetaiotaomicron were significantly higher than that of the western medicine group(both P<0.05),the differences in the expression of Eubacterium rectale and Bacteroides thetaiotaomicron were not statistically significant between the tradi-tional Chinese medicine group and combined group(both P>0.05).Conclusion Decoction for diffusing lung,discharging turbid and calming panting combined with ambroxol is more effective than they used alone in the treatment of patients with stable bronchiectasis of syndrome of phlegm-dampness accumulating lung,which can effectively alleviate the patients'condi-tions and improve their lung function and quality of life,and the mechanism may be related to regulating the microecology of intestinal flora.

bronchiectasisstable stagesyndrome of phlegm-dampness accumulating lungdecoction for diffusing lung,discharging turbid and calming pantingintestinal flora microecology

朱汉平、张志敏、谢栩硕、任培华、王鹏、李振球

展开 >

广州医科大学附属第一医院,广东 广州 510120

支气管扩张 稳定期 痰湿蕴肺型 宣肺降浊清肠汤 肠道菌群微生态

广东省中医药局中医药科研项目广东省中医药局中医药科研项目

2022123620231243

2024

现代中西医结合杂志
中国中西医结合学会河北分会,中华中医药学会

现代中西医结合杂志

CSTPCD
影响因子:1.775
ISSN:1008-8849
年,卷(期):2024.33(7)
  • 18